""

about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

FAculty directory

Back to alphabetical index

Ellen Tedaldi, MD

 

Ellen Tedaldi, MD

 

Professor, Medicine

Director, HIV Program

Telephone:  215-707-1800

Fax:  215-707-3644

Email: ellen.tedaldi@temple.edu

 

Department of Medicine, Section of General Internal Medicine

 

Educational Background:

 

BS, Cornell University, Ithica, NY

 

MD, SUNY Buffalo School of Medicine (Alpha Omega Alpha), Buffalo, NY

 

Residency, Hennepin County Medical Center, Minneapolis, MN

 

Chief Resident, Hennepin County Medical Center, Minneapolis, MN

 

Return to top

 

 

clinical interests:

 

  • HIV
  • Women's health

Return to top

 

 

research interests:

 

HIV clinical trials

 

Return to top

 

 

selected publications:

 

Tedaldi EM, Chen L, Markowitz N, Kelly L, Abrams D and the CPCRA Hepatitis Working Group. Effect of IL-2 on Hepatitis C Virus (HCV) levels in patients coinfected with  Human Immunodeficiency Virus (HIV) receiving HAART. Journal of Viral Hepatitis July 2005, 12(4):414-420.

 

Visnegarwala F, Chen L, Raghavan S, Tedaldi E. Prevalence of diabetes mellitus and dyslipidemia among naive patients co-infected with hepatitis C (HCV) and and HIV-1 compared to patients without co-infection, J of Infection , 2005 May; Vol 50 (4):331-337.

 

Return to top

 

 

PUBMED PUBLICATIONS :


Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

24493009. Tedaldi EM, Richardson JT, Debes R, Young B, Chmiel JS, Durham MD, Brooks JT, Buchacz K, Retention in Care within 1 Year of Initial HIV Care Visit in a Multisite US Cohort: Who's in and Who's Out? J Int Assoc Provid AIDS Care :()2014 Feb 3

23605401. Holtzman C, Armon C, Tedaldi E, Chmiel JS, Buchacz K, Wood K, Brooks JT, Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population. J Gen Intern Med 28:10(1302-10)2013 Oct

23199190. Tedaldi EM, van den Berg-Wolf M, Richardson J, Patel P, Durham M, Hammer J, Henry K, Metzler S, Ínen N, Conley L, Wood K, Brooks JT, Buchacz K, Sadness in the SUN: using computerized screening to analyze correlates of depression and adherence in HIV-infected adults in the United States. AIDS Patient Care STDS 26:12(718-29)2012 Dec

22591357. Wolak C, Bass SB, Tedaldi E, Vandenburg-Wolf M, Rohrer C, Minority HIV patients' perceptions of barriers and facilitators to participation in clinical research. Curr HIV Res 10:4(348-55)2012 Jun

18959492. Tedaldi E, Peters L, Neuhaus J, Puoti M, Rockstroh J, Klein MB, Dore GJ, Mocroft A, Soriano V, Clotet B, Lundgren JD, Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Clin Infect Dis 47:11(1468-75)2008 Dec 1

18681195. Tedaldi EM, Emerging therapies for hepatitis C and HIV in drug abusers: drugs and strategies. J Addict Dis 27:2(83-91)2008

18462073. Berg-Wolf MV, Klibanov OM, Gaughan JP, Tedaldi EM, Ezetimibe Combined with Low-Dose Statin Effectively Lowers LDL in Protease Inhibitor Treated Patients. AIDS Patient Care STDS :()2008 May 7

18373432. Fischer-Smith T, Tedaldi EM, Rappaport J, CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS Res Hum Retroviruses 24:3(417-21)2008 Mar

18176329. Tedaldi EM, Absalon J, Thomas AJ, Shlay JC, van den Berg-Wolf M, Ethnicity, race, and gender. Differences in serious adverse events among participants in an antiretroviral initiation trial: results of CPCRA 058 (FIRST Study). J Acquir Immune Defic Syndr 47:4(441-8)2008 Apr 1

16885779. Tedaldi EM, Brooks JT, Weidle PJ, Richardson JT, Baker RK, Buchacz K, Moorman AC, Wood KC, Holmberg SD, Increased body mass index does not alter response to initial highly active antiretroviral therapy in HIV-1-infected patients. J Acquir Immune Defic Syndr 43:1(35-41)2006 Sep

16265606. Tedaldi EM, New drug targets for HIV and hepatitis C virus coinfection. Clin Infect Dis 41 Suppl 1:(S101-4)2005 Jul 1

15156488. Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD, Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 38:10(1478-84)2004 May 15

12746778. Tedaldi EM, Hullsiek KH, Malvestutto CD, Arduino RC, Fisher EJ, Gaglio PJ, Jenny-Avital ER, McGowan JP, Perez G, Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis 36:10(1313-7)2003 May 15

12539079. Tedaldi EM, Baker RK, Moorman AC, Alzola CF, Furhrer J, McCabe RE, Wood KC, Holmberg SD, Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis 36:3(363-7)2003 Feb 1

11828860. Tedaldi E, Willard S, Gilmore J, Holdsworth C, Dix-Lassiter S, Axelrod P, Continuation of postpartum antiretroviral therapy in a cohort of women infected with human immunodeficiency virus. J Assoc Nurses AIDS Care 13:1(60-5)2002 Jan-Feb

11766416. Tedaldi E, Bean P, Diagnosis, evaluation, and treatment of HIV/HCV coinfection. Am Clin Lab 20:9(26-32)2001 Oct-Nov

Return to top